Clinical TrialsSearch results
Number of results: 553
No Longer Recruiting
- Evaluation of the effect of nutritional therapy intervention in outpatients undergoing chemotherapy
- Digestive organ malignant tumor
- Sato Hiroshi
- 2022-01-25
Other
- Evaluation of the Safety and Efficacy of AL3818 in Subjects with Recurrent or Metastatic Ovarian, Fallopian, and Primary Peritoneal Carcinoma
- Recurrent or metastatic platinum refractory, resistant ovarian, fallopian, primary peritoneal cancer
- Kitano Tina
- 2023-04-07
Other
- Evaluation of usefullness of 1H MR spectroscopy for diagnosis of breast tumors.
- breast tumor
- International medical center, Saitama medical university
- 2009-09-09
Completed
- Examination of airway management methods to prevent COVID-19 infection by viral aerosols produced during cough reflex
- COVID-19
- Okuda Yasuhisa
- 2021-07-30
Recruiting
- Examination of treatment for appendicitis with abscess
- appendicitis with abscess
- Suzuki Toshiyuki
- 2022-06-22
Other
- Exercise and Life Functioning in Patients with Congestive Heart Failure ; A Rehabilitation Cohort Study.
- Patients with congestive heart failure
- Nagoya University School of Health Sciences
- 2007-12-01
Other
- exploratory randomized clinical traial comparing naftopidil with tamsulosin in cases with benign prostatic hypertrophy assciated with overactive bladder
- Benign prostatic hypertophy associated with overactive bladder
- Department of Urology, the University of Tokyo Hospital
- 2009-06-24
Other
- Feasibility study of 5-fluorouracil, leucovorin and paclitaxel (FLTAX) in peritoneal disseminated gastric cancer with massive ascites or inadequate oral intake
- Gastric cancer
- National Cancer Center Hospital
- 2009-06-20
Other
- Feasibility study of neoadjuvant chemotherapy followed by interval cytoreductive surgery for stage III/IV ovarian, tubal and peritoneal cancers.(JCOG0206, OVCA-NAC-P2)
- stage III/IV ovarian, tubal and peritoneal carcinomas
- Japan Clinical Oncology Group(JCOG)
- 2005-06-07
Other
- Feasibility study of S-1 as additional therapy after neo-adjuvant or adjuvant chemotherapy for triple negative breast cancer(SBCCSG-14).
- Primary breast cancer
- Saitama Breast Cancer Clinical Study Group(SBCCSG)
- 2008-10-06